Mark Smith v. HHS - Influenza, Guillain-Barré Syndrome (“GBS”) and/or Transverse Myelitis (“TM”) (2023)

Mark Smith filed a petition on June 26, 2023, seeking compensation under the National Vaccine Injury Compensation Program. He alleged that he suffered Guillain-Barré Syndrome (GBS) and/or Transverse Myelitis (TM) as a result of receiving an influenza vaccine on September 22, 2020, and that he experienced residual effects for more than six months.

The respondent denied that the flu vaccine caused Petitioner's condition and denied that it was a Table injury. Despite these positions, both parties agreed to settle the case through a stipulation filed on June 26, 2023.

Chief Special Master Brian H. Corcoran reviewed the stipulation and found it reasonable, adopting it as the decision awarding damages.

The stipulation awarded Mark Smith a lump sum of $125,000.00, payable by check, as compensation for all damages. Petitioner's counsel was Jessica E.

Choper of Britcher Leone and Sergio, L.L.C., and respondent's counsel was Michael Joseph Lang of the U.S. Dep’t of Justice.

The public decision does not describe the onset of symptoms, specific clinical details, or expert testimony.